This study will evaluate the long-term safety of methylphenidate hydrochloride extended
release in adults with attention deficit/hyperactivity disorder
Minimum age: 18 Years.
Maximum age: 60 Years.
Gender(s): Both.
Novartis Investigative Site, Brugge 8310, Belgium
Novartis Investigative Site, Heusden-Zolder 3550, Belgium
Novartis Investigative Site, Kessel-Lo 3010, Belgium
Novartis Investigative Site, Mechelen 2800, Belgium
Novartis Investigative Site, Uccle 1180, Belgium
Novartis Investigative Site, Antioquia 0000, Colombia
Novartis Investigative Site, Antioquia, Colombia
Novartis Investigative Site, Århus C 8000, Denmark
Novartis Investigative Site, Bamberg 96047, Germany
Novartis Investigative Site, Berlin 10629, Germany
Novartis Investigative Site, Berlin 12203, Germany
Novartis Investigative Site, Dresden 01129, Germany
Novartis Investigative Site, Freiburg 79104, Germany
Novartis Investigative Site, Freiburg 79106, Germany
Novartis Investigative Site, Hamburg 20259, Germany
Novartis Investigative Site, Homburg 66421, Germany
Novartis Investigative Site, Landau 76829, Germany
Novartis Investigative Site, Leipzig 04157, Germany
Novartis Investigative Site, Limburg 65549, Germany
Novartis Investigative Site, Ludwigsburg 71636, Germany
Novartis Investigative Site, Mainz 55131, Germany
Novartis Investigative Site, Mannheim 68159, Germany
Novartis Investigative Site, München 80333, Germany
Novartis Investigative Site, Naumburg 06618, Germany
Novartis Investigative Site, Nürnberg 90419, Germany
Novartis Investigative Site, Siegen 57076, Germany
Novartis Investigative Site, Ulm 89081, Germany
Novartis Investigative Site, Westerstede/Oldenburg 26655, Germany
Novartis Investigative Site, Wolfsburg 38444, Germany
Novartis Investigative Site, Würzburg 97070, Germany
Novartis Investigative Site, Luleå 972 35, Sweden
Novartis Investigative Site, Malmö 211 53, Sweden
Novartis Investigative Site, Little Rock, Arkansas 72205, United States
Novartis Investigative Site, Beverly Hills, California 90210, United States
Novartis Investigative Site, Spring Valley, California 91978-1522, United States
Novartis Investigative Site, Bradenton, Florida 34208, United States
Novartis Investigative Site, Orlando, Florida 32806, United States
Novartis Investigative Site, West Plam Beach, Florida 33407, United States
Novartis Investigative Site, Libertyville, Illinois 60048, United States
Novartis Investigative Site, Owensboro, Kentucky 42301, United States
Novartis Investigative Site, Las Vegas, Nevada 89128, United States
Novartis Investigative Site, Las Vegas, Nevada 89119, United States
Novartis Investigative Site, Fargo, North Dakota 58103, United States
Novartis Investigative Site, Columbus, Ohio 43210, United States
Novartis Investigative Site, Philadelphia, Pennsylvania 19149, United States
Novartis Investigative Site, Houston, Texas 77007, United States
Novartis Investigative Site, Bellevue, Washington 98004, United States
Novartis Investigative Site, Seattle, Washington 98104, United States